1. Home
  2. SQFT vs INDP Comparison

SQFT vs INDP Comparison

Compare SQFT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Presidio Property Trust Inc.

SQFT

Presidio Property Trust Inc.

HOLD

Current Price

$3.30

Market Cap

4.7M

Sector

Real Estate

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQFT
INDP
Founded
1999
2000
Country
United States
United States
Employees
15
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SQFT
INDP
Price
$3.30
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.9K
38.0K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.27
52 Week High
$23.00
$13.24

Technical Indicators

Market Signals
Indicator
SQFT
INDP
Relative Strength Index (RSI) 49.57 27.50
Support Level $3.13 N/A
Resistance Level $3.91 $2.08
Average True Range (ATR) 0.29 0.23
MACD -0.04 -0.11
Stochastic Oscillator 39.82 17.79

Price Performance

Historical Comparison
SQFT
INDP

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: